← Open Payments lookup

NATALIE KOSTER: Open Payments

NPI 1619733532 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$876 in 38 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $188 · 2025 $876

Food & beverage: $876
CompanyPaymentsAmount
Novo Nordisk Inc14$200
AstraZeneca Pharmaceuticals LP5$156
Lilly USA, LLC2$124
PFIZER INC.3$73
SANOFI PASTEUR INC.2$59
Boston Scientific Corporation1$43
GlaxoSmithKline, LLC.2$30
BridgeBio Pharma, Inc.1$28
SHIELD THERAPEUTICS INC1$23
Averitas Pharma Inc.1$23

Products named: KISUNLA, Ozempic, FARXIGA, PREVNAR 20, Wegovy, APOLLO ESG System, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Attruby.

Industry payments across TX — which companies pay providers there.